Alpha-gal syndrome (AGS) is a severe tick-vectored food allergy caused by sensitivity to the galactose-alpha-1,3-galactose ...

Q4 2024 Earnings Call Transcript March 10, 2025 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings ...

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith ...

Scientists have developed a new chemical method that could make it easier, safer and more environmentally friendly to create ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The Mayo Clinic estimates that menopause symptoms lead to $1.8 billion in lost work time per year in the U.S. About 5 percent of employers offer menopause benefits or accommodations such as the ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, ...

Xilio expects to report updated data from the Phase 2 clinical trial in the middle of 2025, including additional response ...